Continuous cardiac index in patients related with left ventricular ejection fraction in preanesthesia assessment for gastroenteroscopy

doi:10.16139/j.1007-9610.2023.02.12

Abstract

Abstract:

Objective To study both non-invasive continuous cardiac index (CCI) and risk factors of coronary heart disease related with left ventricular ejection fraction (LVEF). Methods Retrospective study was done at VIP Health Center with 90 patients with preanesthesia assessment for gastrointestinal endoscopy under intravenous anesthesia between January and March 2022 in our hospital. CCI was measured using non-invasive real-time arterial blood pressure and hemodynamic monitoring system. Risk factors of coronary heart disease were collected. There were three groups of patients according to the results of LVEF gotten from echocardiography examination including group of LVEF 40%-49% (n=15), group of LVEF 50%-59% (n=38) and group of LVEF >60% (n=37). Results The group of LVEF 40%-49% had the highest rate of smoking (60.0%), hypertension (80.0%), diabetes (73.3%), hyperlipidemia (86.6%), obesity (53.3%), family history of early onest cardiovascular disease (33.3%) and the highest rate of ≥3 risk factors of coronary heart disease (80.0%)(P<0.05). The CCI in the group of LVEF 40%-49% was the lowest among three groups (P<0.05). There was a significant positive correlation between CCI and LVEF (r>0.95, P<0.05). Conclusions It was suggested that non-invasive real-time arterial blood pressure and hemodynamic monitoring system could be used for preanesthesia assessment, and CCI related to LVEF, which improves the safety of anesthesia for patients.

Key words: Continuous cardiac index, Left ventricular ejection fraction, Echocardiography, Preanesthesia assessmemt

CLC Number:

R614.2

LU Wei, LI Xuting, YU Weibin, XIA Yimeng, FAN Qiuwei. Continuous cardiac index in patients related with left ventricular ejection fraction in preanesthesia assessment for gastroenteroscopy[J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 152-156.

Figures/Tables 2

References 27

[1]	SAMEED M, CHOI H, AURON M, et al. Preoperative pulmonary risk assessment[J]. Respir Care, 2021, 66(7):1150-1166. doi: 10.4187/respcare.09154 pmid: 34210743
[2]	BIERLE D M, RASLAU D, REGAN D W, et al. Pre-oprative evaluation before noncardiac surgery[J]. Mayo Clin Proc, 2020, 95(4):807-822. doi: 10.1016/j.mayocp.2019.04.029 URL
[3]	OKOCHA O, GERLACH R M, SWEITZER B. Preoperative evaluation for ambulatory anesthesia: what, when, and how?[J]. Anesthesiol Clin, 2019, 37(2):195-213. doi: S1932-2275(19)30016-3 pmid: 31047124
[4]	GUPTA P K, GUPTA H, SUNDARAM A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery[J]. Circulation, 2011, 124(4):381-387. doi: 10.1161/CIRCULATIONAHA.110.015701 pmid: 21730309
[5]	AHMAD F S, NING H, RICH J D, et al. Hypertension,obesity, diabetes, and heart failure-free survival: the cardiovascular disease lifetime risk pooling project[J]. JACC Heart Fail, 2016, 4(12):911-919. doi: 10.1016/j.jchf.2016.08.001 URL
[6]	GALINDO P, GASCA C, ARGAIZ E R, et al. Point of care venous Doppler ultrasound: exploring the missing piece of bedside hemodynamic assessment[J]. World J Crit Care Med, 2021, 10(6):310-322. doi: 10.5492/wjccm.v10.i6.310 pmid: 34888157
[7]	SCHMID DANERS M, HALL S, SÜNDERMANN S, et al. Real-time ventricular volume measured using the intracardiac electromyogram[J]. ASAIO J, 2021, 67(12):1312-1320. doi: 10.1097/MAT.0000000000001444 pmid: 33899813
[8]	MATSUZAWA Y, KWON T G, LENNON R J, et al. Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and mata-analysis[J]. J Am Heart Assoc, 2015, 4(11):e002270.
[9]	中国高血压防治指南修订委员会, 高血压联盟中国, 中华医学会心血管病学分会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1):24-56.
	Writing Group of 2018 Chinese Guidelines for the Ma-nagement of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology, et al. 2018 Chinese guidelines for the management of hypertension[J]. Chin J Cardiovasc Med, 2019, 24(1):24-56.
[10]	中国医师协会内分泌代谢科医师分会, 国家代谢性疾病临床医学研究中心. 糖尿病分型诊断中国专家共识[J]. 中华糖尿病杂志, 2022, 14(2):120-139.
	Chinese Endocrinologist Association, Chinese Medical Doctor Association, National Clinical Research Center for Metabolic Diseases. Classification of diabetes mellitus in China: an expert consensus statement[J]. Chin J Diabetes Mellitus, 2022, 14(2):120-139.
[11]	中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志, 2007, 35(5):390-419.
	Writing Group of Chinese guidelines on prevention and treatment of dyslipidemia in adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults[J]. Chin J Cardiol, 2007, 35(5):390-419.
[12]	SHARMA S, ARORA L. Anesthesia for the morbidly obese patient[J]. Anesthesiol Clin, 2020, 38(1):197-212. doi: S1932-2275(19)30090-4 pmid: 32008653
[13]	OLOTU C. Anesthesia for the elderly: a narrative review[J]. Minerva Anestesiol, 2021, 87(10):1128-1138.
[14]	SAUGEL B, VINCENT J L. Cardiac output monitoring: how to choose the optimal method for the individual patient[J]. Curr Opin Crit Care, 2018, 24(3):165-172. doi: 10.1097/MCC.0000000000000492 pmid: 29621027
[15]	BERNDSEN M. Noninvasive and minimally invasive cardiac output monitoring: a nursing perspective[J]. Dimens Crit Care Nurs, 2022, 41(3):121-123. doi: 10.1097/DCC.0000000000000524 pmid: 36749859
[16]	SCHEEREN T W L, RAMSAY M A E. New developments in hemodynamic monitoring[J]. J Cardiothorac Vasc Anesth, 2019, 33(Suppl 1):S67-S72. doi: 10.1053/j.jvca.2019.03.043 URL
[17]	KOBE J, MISHRA N, ARYA V K, et al. Cardiac output monitoring: technology and choice[J]. Ann Card Anaesth, 2019, 22(1):6-17. doi: 10.4103/aca.ACA_41_18 pmid: 30648673
[18]	WOODMAN H M, LEE C, AHMED A N, et al. Cardiac output monitoring in paediatric cardiac surgery: a review[J]. Cardiol Young, 2021, 31(1):23-30. doi: 10.1017/S1047951120004680 pmid: 33399034
[19]	WISZT R, CZIPPELOVA B, CERNANOVA KROHOVA J, et al. Stroke volume variation as an index of fluid responsiveness can be impaired by mental stress[J]. J Physiol Pharmacol, 2022, 73(2).
[20]	FENTON K E, PARKER M M. Cardiac function and dysfunction in sepsis[J]. Clin Chest Med, 2016, 37(2):289-298. doi: 10.1016/j.ccm.2016.01.014 pmid: 27229645
[21]	OLYMBIOS M, KWIECINSKI J, BERMAN D S, et al. Imaging in heart transplant patients[J]. JACC Cardiovasc Imaging, 2018, 11(10):1514-1530. doi: S1936-878X(18)30640-5 pmid: 30286911
[22]	TEBOUL J L, SAUGEL B, CECCONI M, et al. Less invasive hemodynamic monitoring in critically ill patients[J]. Intensive Care Med, 2016, 42(9):1350-1359. doi: 10.1007/s00134-016-4375-7 URL
[23]	SAUGEL B, KOUZ K, SCHEEREN T W L, et al. Cardiac output estimation using pulse wave analysis-physiology, algorithms, and technologies: a narrative review[J]. Br J Anaesth, 2021, 126(1): 67-76. doi: 10.1016/j.bja.2020.09.049 pmid: 33246581
[24]	XIAO H, LIU D, AVOLIO A P, et al. Estimation of cardiac stroke volume from radial pulse waveform by artificial neural network[J]. Comput Methods Programs Biomed, 2022, 218:106738. doi: 10.1016/j.cmpb.2022.106738 URL
[25]	HUANG S J. Measuring cardiac output at the bedside[J]. Curr Opin Crit Care, 2019, 25(3):266-272. doi: 10.1097/MCC.0000000000000599 pmid: 31022088
[26]	SAUGEL B, MEIDERT A S, LANGWIESER N, et al. An autocalibrating algorithm for non-invasive cardiac output determination based on the analysis of an arterial pressure wave form recorded with radial artery applanation tonometry: a proof of concept pilot analysis[J]. J Clin Monit Comput, 2014, 28(4):357-362. doi: 10.1007/s10877-013-9540-8 URL
[27]	WAGNER J Y, SARWARI H, SCHÖN G, et al. Radial artery applanation tonometry for continuous noninvasive cardiac output measurement: a comparison with intermittent pulmonary artery thermodilution in patients after cardiothoracic surgery[J]. Crit Care Med, 2015, 43(7):1423-1428. doi: 10.1097/CCM.0000000000000979 pmid: 25844700

Item	LVEF 40%-49%	LVEF 50%-59%	LVEF>60%	P value	^*P value	^#P value
Cases	15	38	37
Age (year)(x±s)	60.5±12.3	62.1±11.7	61.3±12.5	0.401
Male/female	8/7	20/18	19/18	0.774
Body mass index(BMI)(x±s)	32.3±1.9	27.3±2.1^*	22.3±1.7^＃		0.003	0.001
Smoking history	9(60.0)	14(36.8)^*	9(24.3)^＃		0.003	0.015
Hypertension	12(80.0)	24(63.2)^*	7(18.9)^＃		0.003	0.006
Diabetes mellitus	11(73.3)	18(47.3)^*	6(16.2)^＃		0.002	0.003
Hyperlipidemia	13(86.6)	19(50.0)^*	4(10.8)^＃		0.001	0.003
Obesity /Overweight with obstructive sleep apnea-hypopnea syndrome	8(53.3)	4(10.5)^*	0(0)^＃		0.001	0.001
Family history of early onset cardiovascular disease	5(33.3)	4(10.5)^*	1(2.7)^＃		0.002	0.003
≥3 risk factors of coronary heart disease	12(80.0)	12(31.6)^*	1(2.7)^＃		0.001	0.002

Item	LVEF40%-49%	LVEF50%-59%	LVEF>60%	^P* value	^#P value
Left ventricular hypertrophy	12(80.0)	24(63.2)^*	6(16.2)^＃	0.026	0.029
Abnormal electrocardiogram	13(86.6)	20(52.6)^*	2(5.4)^＃	0.017	0.026
CCI[L/(min·m²)]	1.7±0.2	2.2±0.3^*	3.7±0.5^＃	0.001	0.002